Advertisement

Why Emergent BioSolutions Stock Soared 47% in the First Half of 2020

Why Emergent BioSolutions Stock Soared 47% in the First Half of 2020

This biotech has emerged as the manufacturing partner of choice for companies developing COVID-19 vaccines.